EP Patent

EP3458110A1 — Methods for making ultrasound contrast agents

Assigned to Lantheus Medical Imaging Inc · Expires 2019-03-27 · 7y expired

What this patent protects

Provided herein are improved methods for preparing phospholipid formulations including phospholipid UCA formulations.

USPTO Abstract

Provided herein are improved methods for preparing phospholipid formulations including phospholipid UCA formulations.

Drugs covered by this patent

Patent Metadata

Patent number
EP3458110A1
Jurisdiction
EP
Classification
—
Expires
2019-03-27
Drug substance claim
No
Drug product claim
No
Assignee
Lantheus Medical Imaging Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.